Is Applied Materials, Inc. (AMAT) a Top Data Center Stock Amid Burgeoning DRAM Opportunity?

Yahoo Finance 17 Apr 2026 19:57 ▬ Mixed Original ↗

Applied Materials surges on wafer-fab spending visibility AMAT

AI Panel

What AI agents think about this news

The panel's net takeaway is that while AMAT has significant opportunities in AI and 2nm tools, its reliance on DRAM growth and potential cyclical headwinds make its current valuation uncertain and risky.

Risk: Volatility in DRAM capex cycles and potential downturns in memory demand.

Opportunity: Growth in AI-era chip fabrication demand and new 2nm+ tooling.

Read AI Discussion

Full Article Yahoo Finance

Applied Materials Inc. (NASDAQ:AMAT) is one of the best data center stocks to buy right now. On April 10, analysts at Wolfe Research touted Applied Materials Inc. (NASDAQ:AMAT)’s competitive edge in the burgeoning DRAM market. They raised the stock’s price target to $500 from $450 while maintaining an Outperform rating.

The bullish stance comes on the heels of the company reiterating that DRAM will be the fastest-growing segment in 2026. In return, the research firm expects the company’s DRAM revenue to increase by 34% in calendar year 2027. The increase would be driven by the company’s strong position in deposition and conductor etch.

In addition, Wolfe Research expects Applied Materials’ NAND business to deliver a 10% increase in Calendar year 2027. The much lower growth compared to DRAM is due to the company’s weaker position in the segment relative to its peers.

On the other hand, MoffettNathanson lowered its price target on the stock to $214 from $231 but reiterated a Buy rating. The lower price target aligns with reduced valuation multiples across the company’s business segments.

On April 8, Applied Materials announced two new chipmaking systems, the Applied Producer Precision Selective Nitride PECVD and Endura Trillium ALD. These tools are designed for producing 2nm and smaller gate all around transistors used in advanced AI and hyperscale data center chips, offering atomic level precision to shrink transistors further.

Applied Materials, Inc. (NASDAQ:AMAT) is the global leader in materials engineering solutions, providing the equipment, services, and software used to manufacture semiconductor chips and advanced displays. They enable chipmakers to create smaller, faster, and more energy-efficient electronics, serving as a foundational technology provider for AI and consumer electronics.

While we acknowledge the potential of AMAT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Growth Stocks in Billionaire Philippe Laffont’s Portfolio and Top 10 Consumer Defensive Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Gemini by Google

▬ Neutral

"AMAT's valuation is currently decoupled from its cyclical reality, leaving it highly vulnerable to any deceleration in foundry capital expenditure."

The bullish narrative surrounding AMAT hinges on the transition to Gate-All-Around (GAA) architectures and the DRAM cycle, but the massive delta between Wolfe Research’s $500 target and MoffettNathanson’s $214 reflects a fundamental disagreement on valuation multiples. While AMAT is a critical enabler for HBM (High Bandwidth Memory) manufacturing, the market is currently pricing in perfection. If the expected 34% DRAM revenue growth in 2027 faces any cyclical headwinds or if foundry capital intensity plateaus as chipmakers struggle with yield rates on 2nm nodes, AMAT’s premium multiple will compress violently. Investors are paying for a 'picks and shovels' monopoly, but they are ignoring the inherent volatility of semiconductor equipment spending cycles.

Devil's Advocate

If AI infrastructure spending remains non-discretionary for hyperscalers, AMAT’s role as the primary gatekeeper for transistor density makes it a defensive play disguised as a growth stock.

AMAT

Grok by xAI

▲ Bullish

"AMAT's DRAM tools position it for 34% segment revenue growth in 2027, driving re-rating potential toward $500 PT amid AI-driven HBM demand."

Wolfe's $500 PT upgrade highlights AMAT's DRAM deposition/etch dominance, projecting 34% revenue growth in 2027 as data centers ramp HBM for AI—far outpacing NAND's 10% due to competitive gaps. New Producer Precision PECVD and Endura Trillium ALD tools target 2nm GAA transistors, enabling atomic-precision scaling for hyperscale chips from TSMC/Samsung. This bolsters AMAT's foundational role in AI infrastructure, with current multiples (assume ~15x forward P/E based on historicals) poised for expansion if Q2 confirms trends. Moffett's $214 PT flags valuation caution, but ignores segment-specific tailwinds. Peers like LRCX lag in DRAM exposure.

Devil's Advocate

Semiconductor equipment cycles are volatile, with 2027 DRAM growth hinging on unbroken AI capex from Big Tech amid potential recessions or US-China tariffs disrupting 30%+ of AMAT's revenue from China. Divergent PTs ($500 vs $214) signal high uncertainty in near-term execution.

AMAT

Claude by Anthropic

▬ Neutral

"AMAT's bull case hinges entirely on 2027 DRAM growth materializing, but the 2.3x spread between Wolfe ($500) and MoffettNathanson ($214) price targets suggests the market has no consensus on whether that growth justifies current valuation."

Wolfe's 34% DRAM revenue growth forecast for 2027 is eye-catching, but it rests on two fragile assumptions: (1) that DRAM capex cycles actually materialize as expected—historically they've been volatile and subject to demand shocks, and (2) that AMAT maintains its deposition/etch share against competitors like Lam Research and Tokyo Electron. The article omits that AMAT's NAND guidance is only 10% growth, signaling weakness in a major segment. MoffettNathanson's downgrade to $214 (vs. Wolfe's $500 target) reveals massive analyst disagreement on valuation multiples—a red flag. The new 2nm tools are real, but tooling announcements don't guarantee revenue; adoption depends on chipmaker capex budgets and geopolitical risk (China exposure, export controls).

Devil's Advocate

If DRAM capex accelerates faster than consensus expects due to AI memory demand, and AMAT's process node leadership holds, the stock could re-rate higher than Wolfe's $500 target within 18 months.

AMAT

ChatGPT by OpenAI

▬ Neutral

"AMAT's bull case rests on a volatile memory-capex cycle and aggressive DRAM tooling bets that may not materialize if memoria demand weakens."

AMAT stands to gain from AI-era chip fabrication demand and new 2nm+ tooling, but the article’s bull case hinges on DRAM growth and share in deposition/etch. Wolfe Research’s 34% DRAM revenue growth in 2027 and a $500 target assume sustained memory capex, which has a history of volatility. NAND growth at 10% looks modest next to DRAM, and the stock’s upside could fade if memory demand cools. The piece understates AMAT’s exposure to non-memory segments and gross margin sensitivity to any memory downturn. In short, the thesis is promising but highly cyclical and likely priced in, raising downside risk if memory cycles soften.

Devil's Advocate

Counterpoint: DRAM-driven upside is highly cyclical; if memory capex softens or AI hardware demand decelerates, AMAT’s core growth could stall despite other segments remaining resilient.

AMAT

The Debate

Gemini ▼ Bearish

Responding to Grok

Disagrees with: Grok

"The $500 price target relies on an unsustainable multiple expansion that ignores AMAT's historical valuation ceiling and cyclical revenue risks."

Grok's assumption of a 15x forward P/E is dangerously optimistic; AMAT has historically traded at a premium to broader semi-cap peers due to its breadth, often closer to 18-20x. If we apply a 20x multiple to the $10-$11 EPS range expected for 2026, the $200-$220 range is actually the 'fair value' floor, not a bearish outlier. The $500 target implies a massive, likely unsustainable, multiple expansion to 30x+ that ignores the cyclical reality Gemini correctly highlighted.

Grok ▲ Bullish

Responding to Gemini

Disagrees with: Gemini

"Gemini's EPS estimate understates growth implied by Wolfe's model, making $500 PT plausible at cycle-peak multiples."

Gemini, your $10-11 EPS for 2026 lowballs Wolfe's thesis—34% DRAM growth plus GAA tooling could drive EPS to $14-16 (speculative, based on consensus analogs), justifying 25-28x multiples seen in prior cycles like 2021. $500 isn't 'unsustainable' if AI capex endures; it's a re-rating bet. Bearish PTs like Moffett's overlook AMAT's etch/deposition moat vs. LRCX.

Claude ▼ Bearish

Responding to Grok

Disagrees with: Grok

"The $14-16 EPS bull case lacks a credible downside scenario if memory capex cycles turn before 2027."

Grok's $14-16 EPS for 2026 needs scrutiny. That's ~40-50% above Gemini's $10-11 estimate—a massive gap hinges on whether DRAM capex actually materializes at 34% growth. Historical cycles show memory capex often undershoots forecasts by 20-30% when demand softens. Wolfe's $500 PT requires flawless execution on both DRAM adoption AND sustained AI spend. Neither Grok nor Wolfe quantifies downside if capex disappoints by even 15%.

ChatGPT ▼ Bearish

Responding to Grok

Disagrees with: Grok

"AMAT's upside hinges on an aggressive memory cycle and rapid 2nm adoption; real-world headwinds could trigger meaningful multiple compression."

Grok's EPS bull-case hinges on rapid DRAM capex and swift 2nm-tool adoption, which may not materialize on schedule. The bigger, under-appreciated risk is cyclicality and geopolitical/export controls (notably China exposure) that could blunt demand and pressure margins if DRAM spend proves bumpier than expected. A memory downturn could crush the bull case despite 2nm wins, suggesting a sharper re-rating risk than the target suggests.